Clinical Trial Update: Study of TA-NIC to Assess the Efficacy and Safety of the Vaccine as an Aid to Smoking Cessation [Phase 2]

View source ↗

Summary

Phase 2 study of the TA-NIC vaccine to aid smoking cessation has completed, assessing its efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence

Drugs mentioned

• TA-NIC

Snippet

Sponsor: Celtic Pharma Development Services | Conditions: Smoking | Phase 2 | Status: COMPLETED